RxDoctor Payments DataLook up a doctor →

Melanie Araujo

Nurse Practitioner · Fall River, MANPI 1295921120

Payments from drug & device makers

$11,857in general payments, 2019–2025

Across 599 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$1K
  • GSK$697
  • Novo Nordisk$625
  • Otsuka America Pharmaceutical, Inc.$536
  • Ardelyx, Inc.$521
  • plus $6K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca58$1,669
AbbVie69$1,433
GSK37$697
Novo Nordisk40$625
Otsuka America Pharmaceutical, Inc.26$536
Ardelyx, Inc.27$521
Bayer27$505
Pfizer22$409
Merck20$391
Lilly USA, LLC22$351
Phathom Pharmaceuticals, Inc.15$337
E.r. Squibb & Sons, L.L.C.15$310
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC16$302
Johnson & Johnson14$292
Boehringer Ingelheim12$280
Sumitomo Pharma America, Inc.17$257
Takeda Pharmaceuticals U.S.A., Inc.28$252
Lundbeck LLC9$190
Exact Sciences6$174
Verona Pharma, Inc.8$163
Abbott8$160
Amgen6$142
Alnylam Pharmaceuticals Inc.6$139
Sunovion Pharmaceuticals Inc.8$128
Dexcom, Inc.5$109
Paratek Pharmaceuticals, Inc.6$109
Novartis6$106
Kowa Pharmaceuticals America, Inc.7$105
Xeris Pharmaceuticals, Inc.5$102
Covis Pharma GmbH5$101
Ironwood Pharmaceuticals, Inc4$93
Mylan Specialty L.p.4$85
Biohaven Pharmaceutical Holding Company Ltd.4$81
Seqirus USA Inc4$65
Biohaven Pharmaceuticals, Inc.3$55
Teva Pharmaceuticals USA, Inc.3$54
Amarin Pharma, Inc.3$53
Eisai Inc.3$53
Urovant Sciences Inc2$47
Astellas Pharma US Inc2$36
Mayne Pharma Commercial LLC1$30
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$26
RGH Enterprises LLC1$24
Viatris Specialty LLC1$24
Arbor Pharmaceuticals, Inc.1$23
Biogen1$22
Mannkind Corporation1$22
Ferring Pharmaceuticals Inc.1$21
Insmed, Inc.1$21
Nestle Healthcare Nutrition Inc.1$19
Currax Pharmaceuticals LLC1$18
Shield Therapeutics Inc1$17
Tonix Medicines, Inc.1$16
Lucid Diagnostics Inc.1$15
Esperion Therapeutics, Inc.1$14
Edwards Lifesciences1$14
Bausch Health US, LLC1$13

How this compares

$11,857 in reported general payments places this provider in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.

See all nurse practitioner providers in Massachusetts

Medicare billing

Part B allowed, 2024
$130,834
Medicare patients
322
Services billed
2,748

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Fall River

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →